MedPath

Neothetics, Inc.

Neothetics, Inc. logo
🇺🇸United States
Ownership
Private, Subsidiary
Employees
1
Market Cap
-
Website
http://www.neothetics.com

Clinical Trials

11

Active:0
Completed:10

Trial Phases

3 Phases

Phase 1:1
Phase 2:9
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 2
9 (81.8%)
Phase 1
1 (9.1%)
Phase 3
1 (9.1%)

Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat

Phase 2
Completed
Conditions
Submental Fat
Interventions
Drug: Placebo for LIPO-202
First Posted Date
2016-12-29
Last Posted Date
2017-10-20
Lead Sponsor
Neothetics, Inc
Target Recruit Count
162
Registration Number
NCT03005717
Locations
🇺🇸

Clinical Testing of Beverly Hills, Beverly Hills, California, United States

🇺🇸

Ablon Skin Institute And Research Center, Manhattan Beach, California, United States

🇺🇸

AboutSkin Research, Greenwood Village, Colorado, United States

and more 8 locations

Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects

Phase 2
Completed
Conditions
Central Abdominal Bulging
Interventions
Drug: Placebo
First Posted Date
2015-10-05
Last Posted Date
2015-12-24
Lead Sponsor
Neothetics, Inc
Target Recruit Count
120
Registration Number
NCT02568319
Locations
🇺🇸

Diagnamics, Inc., Encinitas, California, United States

🇺🇸

Ablon Skin Institute and Research Center, Manhattan Beach, California, United States

🇺🇸

The Center for Clinical & Cosmetic Research, Aventura, Florida, United States

and more 3 locations

An Open-Label Study to Evaluate Retreatment With LIPO-202

Phase 2
Conditions
Central Abdominal Bulging
Interventions
First Posted Date
2015-03-25
Last Posted Date
2015-08-13
Lead Sponsor
Neothetics, Inc
Target Recruit Count
150
Registration Number
NCT02397525
Locations
🇺🇸

AboutSkin Dermatology, Englewood, Colorado, United States

🇺🇸

Dermatology Research Institute, LLC, Coral Gables, Florida, United States

🇺🇸

Gwinnett Clinical Research Center, Inc, Snellville, Georgia, United States

and more 5 locations

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat

Phase 3
Completed
Conditions
Central Abdominal Bulging
Interventions
Drug: Placebo
First Posted Date
2015-03-25
Last Posted Date
2016-01-08
Lead Sponsor
Neothetics, Inc
Target Recruit Count
800
Registration Number
NCT02397499
Locations
🇺🇸

WG Clinical Research, Tucson, Arizona, United States

🇺🇸

Burke Pharmaceutical Research, Hot Springs, Arkansas, United States

🇺🇸

Clinical Testing Center of Beverly Hills, Beverly Hills, California, United States

and more 28 locations

Dose Ranging Study

Phase 2
Completed
Conditions
Periumbilical Subcutaneous Adipose Tissue Reduction
First Posted Date
2013-03-01
Last Posted Date
2015-03-26
Lead Sponsor
Neothetics, Inc
Target Recruit Count
472
Registration Number
NCT01802723
Locations
🇺🇸

United States, California, Santa Ana, California, United States

🇺🇸

United States, Florida, Tampa, Florida, United States

🇺🇸

United States, Illinois, Chicago, Illinois, United States

and more 4 locations
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.